Efficacy and Tolerability of Tazarotene Lotion for Truncal Acne
Tazarotene lotion uses polymeric emulsion technology to improve skin barrier function, according to a poster presentation at the 2022 SDPA Conference.
How to Properly Use Lasers in Skin of Color Patients
Andrew Alexis, MD, shares his best tips for appropriate laser use in skin of color patients at the 2022 SDPA Conference.
Review of Handheld Elastic-Scattering Spectroscopy Device on Melanoma Lesions
A poster presentation from the 2022 SDPA Conference reviewed an elastic-scattering spectroscopy device for melanoma detection.
Updates on Psoriasis and Related Comorbidities
Shanna Miranti, MPAS, PA-C, shares highlights from her shared session at the 2022 SDPA Conference.
Pediatric Literature Updates
At the 2022 SDPA Conference, Lucia Diaz, MD, reviews literature updates to help physicians better care for pediatric patients.
High-Risk Tumors: BCC and SCC
Zeena Nawas, MD, discussed the clinical presentations, evaluation, and management of high-risk cutaneous tumors at the 2022 SDPA Conference.
Updates on Treating Warts, Molluscum Contagiosum, and Other Pediatric Conditions
Shanna Miranti, MPAS, PA-C, shares highlights from her first session at the 2022 SDPA Conference in Miami, Florida.
Off-Label Therapeutics in Adult Patients
At the 2022 SDPA Conference, Ted Rosen, MD, discusses how to use off-label therapeutics for adult dermatologic conditions to optimize treatments.
Psoriasis in Intertriginous Areas Has Negative Impact on Well-Being and Sexual Health
At a poster presentation at the 2022 SDPA Conference, patients with psoriasis reported symptoms in intertriginous areas at some point during the duration of their psoriasis.
An Overview of Dermoscopy
At the 2022 SDPA Conference, Orit Markowitz, MD, reviews dermoscopy and other imaging modalities that allow for more practical ways to treat patients' lesions.
Shanna Miranti, MPAS, PA-C, Shares What She’s Looking Forward to at SDPA
As the Society of Dermatology Physician Assistants Conference begins this week, speakers share what they’re excited about.
The Mainstream Patient: November 14
This week's edition of the Mainstream Patient features stories about "botox in a bottle" products, how to treat cystic acne, face positivity, and more.
What's New on Dermatology Times®: November 14-18
Click here to see a preview of what to expect this week.
The Weekly Roundup: November 7-11
ICYMI, this week we had stories about IL-17 inhibitor durability in plaque psoriasis, benzene contamination in dry shampoo products, an interview with Muneeb Shah, DO, and more.
Positive New Results of Tapinarof Cream Study for Pediatric Patients with AD
Dermavant announced positive results from its pediatric maximal usage study.
Eli Lilly Submits BLA for Lebrikizumab AD Treatment
BLA submission is based on phase 3 trial results evaluating the safety and efficacy of lebrikizumab.
Muneeb Shah, DO, Discusses What it Means to Have Healthy Skin
November kicks off National Healthy Skin Month, presenting an opportunity to learn new habits for healthier skin.
David Light, CEO of Valisure, Reviews Petition Sent to FDA Regarding Benzene Contamination
Valisure, an independent laboratory, recently sent a Citizen's Petition to the FDA regarding high levels of benzene found in dry shampoo products.
FDA Accepts Phase 1 Clinical Trials of Exosome Therapy for AD
Brexogen Inc.’s exosome therapy is the first entry of a clinical trial of exosome treatment for atopic dermatitis.
The Mainstream Patient: November 7
This week's edition of the Mainstream Patient features stories about how to take care of the skin's microbiome, Clinique's commitment to the Latinx community, laser treatment results for rosacea, and more.
The Weekly Roundup: October 31-November 4
ICYMI, this week we had stories about blastic plasmacytoid dendritic cell neoplasm, epidermolysis bullosa, an interview with Seth Matarasso, MD, and more.
Warning: Concerning Levels of Benzene Detected in Dry Shampoo Products
Christopher Bunick, MD, PhD, shares his thoughts on the latest report of concerning levels of benzene, a human carcinogen, found in dry shampoos recalled last month.
Innovations in Neuromodulators
Seth Matarasso, MD, discusses upcoming innovations in neuromodulators and additional highlights from his presentation at ASDS in Denver, Colorado.
Study Evaluates Safety and Efficacy of Oral Zinc and Low-Dose Isotretinoin for Acne Vulgaris
Numerous adverse effects are associated with standard-dose isotretinoin.
PROMs Rarely Used in Randomized Clinical Trials for Acne and Rosacea
Patient-reported outcome measures ensure patients' experiences are documented during new treatments.
What's Trending in Skin Care: October 2022
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of October.
The Weekly Roundup: October 24-28
ICYMI, this week we had stories about product recalls due to benzene, advanced wound care in the US, a Fall Clinical recap, and more.
Recap from Fall Clinical
Catch up on coverage from the 2022 Fall Clinical Dermatology Conference.
New Aveeno Report Reveals 71% of Adults Have Sensitive Skin
State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.
Phase 3 Results of Epidermolysis Bullosa Trial Published in British Journal of Dermatology
Amryt Pharma’s phase 3 trial, EASE, is the largest phase 3 trial in epidermolysis bullosa.